Associazione Nazionale Medici Cardiologi Ospedalieri

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
VAGAL INFLUENCE ON ATRIAL ELECTROGRAMS: DIFFERENTIATING STRUCTURAL VS. FUNCTIONAL FRAGMENTATION IN GANGLIONATED PLEXI REGIONS
Anno:
2026
Background and aims: Ganglionated plexi (GPs) are the primary target of ablative therapies for neurally mediated syncope (NMS); however, the optimal method for their endocardial localization remains unclear. This study analyzed bipolar atrial electrograms (EGMs) and their response to a vagolytic agent to elucidate their relationship with the parasympathetic…
IMPROVING MORTALITY PREDICTION IN CARDIAC SURGERY: A BAYESIAN ENSEMBLE APPROACH BEYOND EUROSCORE II
Anno:
2026
Background Risk stratification in cardiac surgery is of utmost importance for informed consent and for the heart team decision. While EuroSCORE II is widely used, it overlooks intraoperative factors such as ischemic and reperfusion times that can substantially affect outcomes. This study evaluates a Bayesian ensemble approach that integrates…
ROLE OF GLP1 AGONIST AFTER TAVI: INSIGHTS FROM MOTIVE REGISTRY
Anno:
2026
Introduction: GLP-1a are a novel class of cardiometabolic drugs that have been shown to reduce the risk of MACE and cardiovascular mortality in patients with type 2 diabetes, overweight, or obesity. Improved outcomes have also been reported in patients undergoing TAVI treated with the SGLT2 inhibitor dapagliflozin in the…
VARIATION IN COMBINED CARDIOPULMONARY EXERCISE TEST AND STRESS ECHOCARDIOGRAPHY FINDINGS IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHYC CARDIOMYOPATHY TREATED WITH MAVACAMTEN: A PROSPECTIVE OBSERVATIONAL MULTICENTER STUDY
Anno:
2026
Background : Mavacamten, a selective cardiac myosin inhibitor, improves left ventricular outflow tract (LVOT) obstruction and symptoms in obstructive hypertrophic cardiomyopathy (HCM). However, real-world data integrating cardiopulmonary exercise testing (CPET) and echocardiography remain limited. Methods : In this prospective multicenter study, 28 patients with symptomatic obstructive HCM underwent transthoracic…
CONCORDANCE BETWEEN INVASIVE AND ECHOCARDIOGRAPHIC METRICS IN PATIENTS WITH SEVERE TRICUSPID REGURGITATION
Anno:
2026
Background: Right ventricular–pulmonary arterial (RV–PA) coupling, expressed as the ratio of end-systolic to arterial elastance (Ees/Ea), is a key marker of RV efficiency and prognosis in advanced tricuspid regurgitation (TR). Non-invasive surrogates of coupling may help identify patients who could benefit from transcatheter tricuspid valve repair (TTVR). Methods: Forty-three…
FROM FIRST DIAGNOSTIC EVALUATION TO NON-DILATED LEFT VENTRICULAR CARDIOMYOPATHY: THE ADDED VALUE OF CARDIAC MAGNETIC RESONANCE
Anno:
2026
Background: Non-dilated left ventricular cardiomyopathy (NDLVC) is a heterogeneous and evolving entity, recently recognized as a distinct category in the 2023 European Society of Cardiology (ESC) Guidelines. Cardiac magnetic resonance (CMR) enables a multiparametric assessment, with myocardial strain emerging as a key functional marker. However, genotype–phenotype correlations in NDLVC…
ZERO-FLUOROSCOPY CATHETER ABLATION FOR THE TREATMENT OF VENTRICULAR PRE-EXCITATION IN PEDIATRIC PATIENTS. A LONG TERM MONOCENTRIC EXPERIENCE
Anno:
2026
Background. Ventricular pre-excitation, affecting 0.1-0.3% of the general population. This condition can lead to re-entrant tachyarrhythmias and, in rare cases, sudden cardiac death, even in asymptomatic individuals. Catheter ablation of accessory patway is often the resolutive treatment, however, in the pediatric population, it must be performed at highly experienced…
THE CLINICAL IMPLICATIONS OF RENAL DOPPLER ULTRASONOGRAPHY FOR PREDICTING CHRONIC KIDNEY DISEASE AND FONTAN FAILURE
Anno:
2026
Background: Renal congestion caused by increased central venous pressure has been one of the main pathophysiologic findings in the Fontan associated kidney dysfunction.Despite widespread availability of screening tools for renal function, data regarding the kidney diseases in Fontan patients are very limited.We aim to characterize new approaches to evaluate…
MYOCARDIAL FIBROSIS IN CARDIAC AMYLOIDOSIS: EVIDENCE FROM LEFT VENTRICULAR ENDOMYOCARDIAL BIOPSIES
Anno:
2026
Background: Treatment options for cardiac amyloidosis (CA) are rapidly expanding. Therapies suppressing further amyloid accumulation may enable partial amyloid reabsorption; emerging monoclonal antibodies may further enhance amyloid clearance. Myocardial fibrosis, triggered by cardiac injury and amyloid deposition, may be less reversible. Fibrosis data in CA remain limited and mostly…
LONG-TERM FOLLOW-UP OF DEFIBRILLATOR IMPLANTATION IN PEDIATRIC AGE: A SINGLE TERTIARY CENTER EXPERIENCE
Anno:
2026
BACKGROUND Despite sudden cardiac death (SCD) is a rare phenomenon in pediatric age, the use of the implantable defibrillator (ICD) is progressively increasing in consideration of its life-saving role both in primary and in secondary prevention. The aim of this study is to assess the long-term follow-up of pediatric…